2. Javaeed A, Ghauri SK. 2019; MCT4 has a potential to be used as a prognostic biomarker - a systematic review and meta-analysis. Oncol Rev. 13(2):403. DOI:
10.4081/oncol.2019.403. PMID:
31410246. PMCID:
PMC6661531.
3. Pérez-Tomás R, Pérez-Guillén I. 2020; Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers (Basel). 12(11):3244. DOI:
10.3390/cancers12113244. PMID:
33153193. PMCID:
PMC7693872.
4. Nakayama Y, Torigoe T, Inoue Y, Minagawa N, Izumi H, Kohno K, et al. 2012; Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer. Exp Ther Med. 3(1):25–30. DOI:
10.3892/etm.2011.361. PMID:
22969839. PMCID:
PMC3438655.
5. Curry JM, Tuluc M, Whitaker-Menezes D, Ames JA, Anantharaman A, Butera A, et al. 2013; Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle. 12(9):1371–84. DOI:
10.4161/cc.24092. PMID:
23574725. PMCID:
PMC3674065.
6. Bisetto S, Whitaker-Menezes D, Wilski NA, Tuluc M, Curry J, Zhan T, et al. 2018; Monocarboxylate transporter 4 (MCT4) knockout mice have attenuated 4NQO induced carcinogenesis; a role for MCT4 in driving oral squamous cell cancer. Front Oncol. 8:324. DOI:
10.3389/fonc.2018.00324. PMID:
30211114. PMCID:
PMC6120975.
7. Kim Y, Choi JW, Lee JH, Kim YS. 2015; Expression of lactate/H(+) symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses. Hum Pathol. 46(1):104–12. DOI:
10.1016/j.humpath.2014.09.013. PMID:
25456395.
8. Izumi H, Takahashi M, Uramoto H, Nakayama Y, Oyama T, Wang KY, et al. 2011; Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci. 102(5):1007–13. DOI:
10.1111/j.1349-7006.2011.01908.x. PMID:
21306479.
9. Gallagher SM, Castorino JJ, Wang D, Philp NJ. 2007; Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res. 67(9):4182–9. DOI:
10.1158/0008-5472.CAN-06-3184. PMID:
17483329.
10. Khatami F, Payab M, Sarvari M, Gilany K, Larijani B, Arjmand B, et al. 2019; Oncometabolites as biomarkers in thyroid cancer: a systematic review. Cancer Manag Res. 11:1829–41. DOI:
10.2147/CMAR.S188661. PMID:
30881111. PMCID:
PMC6395057.
11. de la Cruz-López KG, Castro-Munoz LJ, Reyes-Hernandez DO, Garcia-Carranca A, Manzo-Merino J. 2019; Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol. 9:1143. DOI:
10.3389/fonc.2019.01143. PMID:
31737570. PMCID:
PMC6839026.
12. Zhao B, Aggarwal A, Im SY, Viswanathan K, Landa I, Nehs MA. 2022; Effect of lactate export inhibition on anaplastic thyroid cancer growth and metabolism. J Am Coll Surg. 234(6):1044–50. DOI:
10.1097/XCS.0000000000000226. PMID:
35703795.
13. Jeon MJ, You MH, Han JM, Sim S, Yoo HJ, Lee WK, et al. 2020; High phosphoglycerate dehydrogenase expression induces stemness and aggressiveness in thyroid cancer. Thyroid. 30(11):1625–38. DOI:
10.1089/thy.2020.0105. PMID:
32438862. PMCID:
PMC7869887.
14. Curry JM, Tassone P, Cotzia P, Sprandio J, Luginbuhl A, Cognetti DM, et al. 2016; Multicompartment metabolism in papillary thyroid cancer. Laryngoscope. 126(10):2410–8. DOI:
10.1002/lary.25799. PMID:
26666958. PMCID:
PMC4909595.
15. Nahm JH, Kim HM, Koo JS. 2017; Glycolysis-related protein expression in thyroid cancer. Tumour Biol. 39(3):1010428317695922. DOI:
10.1177/1010428317695922. PMID:
28347233.
16. Sung TY, Kim M, Kim TY, Kim WG, Park Y, Song DE, et al. 2015; Negative expression of CPSF2 predicts a poorer clinical outcome in patients with papillary thyroid carcinoma. Thyroid. 25(9):1020–5. DOI:
10.1089/thy.2015.0079. PMID:
26148673.
18. Halestrap AP, Meredith D. 2004; The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447(5):619–28. DOI:
10.1007/s00424-003-1067-2. PMID:
12739169.
19. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S. 2000; The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J. 350 Pt 1(Pt 1):219–27. DOI:
10.1042/bj3500219. PMID:
10926847. PMCID:
PMC1221245.
20. Romero-Garcia S, Moreno-Altamirano MM, Prado-Garcia H, Sanchez-Garcia FJ. 2016; Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front Immunol. 7:52. DOI:
10.3389/fimmu.2016.00052. PMID:
26909082. PMCID:
PMC4754406.
21. Wen SS, Zhang TT, Xue DX, Wu WL, Wang YL, Wang Y, et al. 2019; Metabolic reprogramming and its clinical application in thyroid cancer. Oncol Lett. 18(2):1579–84. DOI:
10.3892/ol.2019.10485. PMID:
31423225. PMCID:
PMC6607326.